S&P 500   5,258.09 (+0.18%)
DOW   39,811.48 (+0.13%)
QQQ   444.20 (-0.14%)
AAPL   171.75 (-0.90%)
MSFT   420.47 (-0.23%)
META   487.49 (-1.29%)
GOOGL   150.91 (+0.03%)
AMZN   180.16 (+0.18%)
TSLA   176.35 (-1.94%)
NVDA   902.94 (+0.05%)
NIO   4.51 (-3.43%)
AMD   180.40 (+0.45%)
BABA   72.47 (+1.23%)
T   17.64 (+0.51%)
F   13.19 (+1.00%)
MU   117.87 (-1.07%)
CGC   8.52 (-10.79%)
GE   175.09 (-2.79%)
DIS   122.50 (+1.26%)
AMC   3.66 (-15.67%)
PFE   27.91 (+0.47%)
PYPL   67.13 (+0.84%)
XOM   116.06 (+0.95%)
S&P 500   5,258.09 (+0.18%)
DOW   39,811.48 (+0.13%)
QQQ   444.20 (-0.14%)
AAPL   171.75 (-0.90%)
MSFT   420.47 (-0.23%)
META   487.49 (-1.29%)
GOOGL   150.91 (+0.03%)
AMZN   180.16 (+0.18%)
TSLA   176.35 (-1.94%)
NVDA   902.94 (+0.05%)
NIO   4.51 (-3.43%)
AMD   180.40 (+0.45%)
BABA   72.47 (+1.23%)
T   17.64 (+0.51%)
F   13.19 (+1.00%)
MU   117.87 (-1.07%)
CGC   8.52 (-10.79%)
GE   175.09 (-2.79%)
DIS   122.50 (+1.26%)
AMC   3.66 (-15.67%)
PFE   27.91 (+0.47%)
PYPL   67.13 (+0.84%)
XOM   116.06 (+0.95%)
S&P 500   5,258.09 (+0.18%)
DOW   39,811.48 (+0.13%)
QQQ   444.20 (-0.14%)
AAPL   171.75 (-0.90%)
MSFT   420.47 (-0.23%)
META   487.49 (-1.29%)
GOOGL   150.91 (+0.03%)
AMZN   180.16 (+0.18%)
TSLA   176.35 (-1.94%)
NVDA   902.94 (+0.05%)
NIO   4.51 (-3.43%)
AMD   180.40 (+0.45%)
BABA   72.47 (+1.23%)
T   17.64 (+0.51%)
F   13.19 (+1.00%)
MU   117.87 (-1.07%)
CGC   8.52 (-10.79%)
GE   175.09 (-2.79%)
DIS   122.50 (+1.26%)
AMC   3.66 (-15.67%)
PFE   27.91 (+0.47%)
PYPL   67.13 (+0.84%)
XOM   116.06 (+0.95%)
S&P 500   5,258.09 (+0.18%)
DOW   39,811.48 (+0.13%)
QQQ   444.20 (-0.14%)
AAPL   171.75 (-0.90%)
MSFT   420.47 (-0.23%)
META   487.49 (-1.29%)
GOOGL   150.91 (+0.03%)
AMZN   180.16 (+0.18%)
TSLA   176.35 (-1.94%)
NVDA   902.94 (+0.05%)
NIO   4.51 (-3.43%)
AMD   180.40 (+0.45%)
BABA   72.47 (+1.23%)
T   17.64 (+0.51%)
F   13.19 (+1.00%)
MU   117.87 (-1.07%)
CGC   8.52 (-10.79%)
GE   175.09 (-2.79%)
DIS   122.50 (+1.26%)
AMC   3.66 (-15.67%)
PFE   27.91 (+0.47%)
PYPL   67.13 (+0.84%)
XOM   116.06 (+0.95%)
NYSE:ISR

Isoray (ISR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.28
$0.42
52-Week Range
N/A
Volume
145,000 shs
Average Volume
290,697 shs
Market Capitalization
$54.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ISR stock logo

About Isoray Stock (NYSE:ISR)

IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.

ISR Stock News Headlines

French ISR Label Revamp Report
Why IsoRay (ISR) Is Plunging Today
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
Why IsoRay (ISR) Stock Is Surging Today
IsoRay (ISR) Reports Q2 Loss, Misses Revenue Estimates
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
Isoray, Inc. (ISR) Q1 2023 Earnings Call Transcript
See More Headlines
Receive ISR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Isoray and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/10/2021
Today
3/28/2024
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-7,270,000.00
Net Margins
-115.91%
Pretax Margin
-91.45%

Debt

Sales & Book Value

Annual Sales
$10.80 million
Book Value
$0.43 per share

Miscellaneous

Free Float
138,674,000
Market Cap
$54.57 million
Optionable
Not Optionable
Beta
1.48
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Lori A. Woods
    Chief Executive Officer & Director
  • Jennifer Streeter
    Chief Operating Officer & VP-Human Resources
  • Mark J. Austin
    Co-CFO, Secretary & Chief Accounting Officer
  • Jonathan R. Hunt
    CFO & Principal Financial Officer
  • William A. Cavanagh
    Chief Research & Development Officer

ISR Stock Analysis - Frequently Asked Questions

How were Isoray's earnings last quarter?

Isoray, Inc. (NYSE:ISR) released its earnings results on Wednesday, November, 10th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.01) by $0.01. The firm earned $2.56 million during the quarter, compared to analysts' expectations of $2.58 million. Isoray had a negative net margin of 115.91% and a negative trailing twelve-month return on equity of 17.12%.

This page (NYSE:ISR) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners